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Abstract 
Background: It is well-understood that ascidians accumulate high levels of vanadium, a 
reduced form of V(III), in an extremely acidic vacuole in their blood cells. Vanabins are small 
cysteine-rich proteins that have been identified only from vanadium-rich ascidians. A previous 
study revealed that Vanabin2 can act as a V(V)-reductase in the glutathione cascade. 
Methods: AsTrx1, A thioredoxin gene, was cloned from the vanadium-rich ascidian, Ascidia 
sydneiensis samea, by PCR. AsTrx1 and Vanabin2 were prepared as recombinant proteins, 
and V(V)-reduction by Vanabin2 was assessed by ESR and ion-exchange column 
chromatography. Site-directed mutagenesis was performed to examine the direct involvement 
of cysteine residues. Tissue expression of AsTrx1 was also examined by RT-PCR. 
Results: When reduced AsTrx1 and Vanabin2 were combined, Vanabin2 adopted an SS/SH 
intermediate structure while V(V) was reduced to V(IV). The loss of cysteine residues in 
either Vanabin2 or AsTrx1 caused a significant loss of reductase activity. Vapp and Kapp values 
for Vanabin2-catalyzed V(V)-reduction in the thioredoxin cascade were 0.066 
mol-V(IV)/min/mol-Vanabin2 and 0.19 mM, respectively. The Kapp value was 2.7-fold lower 
than that observed in the glutathione cascade. The AsTrx1 gene was expressed at a very high 
level in blood cells, in which Vanabins 1–4 were co-expressed. 
Conclusions: AsTrx1 may contribute to a significant part of the redox cascade for 
V(V)-reduction by Vanabin2 in the cytoplasm of vanadocytes, but prevails only at low V(V) 
concentrations. 
General significance: This study is the first to report the reduction of V(V) in the thioredoxin 
cascade. 
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1. Introduction 
 
   The unusual ability of ascidians to accumulate high levels of vanadium ions has been 
attracting attention in biological and chemical disciplines for over a century since the original 
finding by Henze (1911) [1]. The maximum concentration of vanadium can reach 350 mM in 
vanadocytes of Ascidia gemmata, belonging to the class Ascidiidae, which is believed to be 
the highest metal accumulation of any living organism [2]. Vanadium usually exists as V(V) 
in HVO42- or H2VO4- in natural aquatic environments. These ions are reduced to V(III) via a 
V(IV) state (VO2+) during assimilation in ascidians [3]. Most vanadium ions are stored in the 
vacuoles of one type of blood cell, specifically signet ring cells, called vanadocytes 
(vanadium-accumulating cells) [2]. Ongoing research during the last two decades has 
identified many proteins involved in the process of accumulating and reducing vanadium in 
vanadocytes, blood plasma, and the digestive tract of ascidians. Among these, the proteins 
that could be responsible for the selective transport of vanadium are the vanadium-binding 
proteins, vanabins. 
   Vanabins generally contain 18 conserved cysteine residues and constitute a unique protein 
family present only in vanadium-rich ascidians [4-8]. The most studied vanabin is Vanabin2, 
which was isolated from Ascidia sydneiensis samea [7,9,10]. The three-dimensional structure 
of Vanbin2 was determined by nuclear magnetic resonance (NMR), which revealed 18 
cysteine residues that comprise nine disulfide (SS) bonds between specific pairs of amino acid 
residues [11]. Although Vanabin2 was originally isolated as a V(IV)-binding protein, it was 
later determined to adopt an SS/SH intermediate structure and one that can act as a 
V(V)-reductase [12,13]. Based on previous studies, we hypothesized that the mechanism of 
action of Vanabin2 is similar to the cascade shown in Scheme 1. In this cascade, electrons are 
transferred from the donor NADPH to glutathione (GSH) via glutathione reductase (GR), and 
then to the acceptor V(V) ions via thiol–disulfide exchange reactions of Vanabin2.  
   On the other hand, another universally important redox factor in biological systems is 
thioredoxin (Trx). Trx was first identified as a low-molecular-weight redox protein in the 
deoxycytidine diphosphate synthesis pathway in Escherichia coli, together with thioredoxin 
reductase (TrxR) [14]. The Trx, TrxR and NADPH system is, thereafter, found in all types of 
organisms from Archaea to humans. Reduced Trx serves as an electron donor for enzymes 
such as ribonucleotide reductases, peroxiredoxins, and methionine sulfoxide reductases, and 
is common to many organisms and organism-specific functions in higher organisms [15]. 
Thus, we hypothesize that Trx may participate in the redox cascade for V(V)-reduction by 
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Vanabin2 (Scheme 2). 
   In this study, we first isolated a homolog of Trx from the vanadium-rich ascidian A. 
sydneiensis samea to examine the participation of Trx in V(V)-reduction. We examined the 
redox cascade shown in Scheme 2 using recombinant Vanabin2 and Trx in in vitro reductase 
assays. Tissue localization of Trx was also examined by real-time polymerase chain reaction 
(RT-PCR). 
 
2. Materials and methods 
 
2.1. Reagents 
 
   Dithiothreitol (DTT), 2-mercaptoethanol (2-ME), and reduced GSH were purchased from 
Wako Pure Chemical Industries. Sodium orthovanadate (Na3VO4; >99.9%) was purchased 
from Sigma-Aldrich Co. Human thioredoxin (HsTrx1) was purchased from Oriental Yeast Co., 
Ltd., as a recombinant protein. 
 
2.2. Animals 
 
   Ascidian A. sydneiensis samea adults were collected at Yamada Bay, Iwate, Japan, and 
Kojima Port, Okayama, Japan. Blood was extracted and diluted with Ca2+- and Mg2+-free 
artificial sea water (460 mM NaCl, 9 mM KCl, 32 mM Na2SO4, 6 mM NaHCO3, 5 mM 
HEPES, and 5 mM EDTA, pH 7.0). Blood cells were collected by centrifugation at 300 × g 
for 10 min at 4°C. Giant cells were removed by sucrose density gradient centrifugation, as 
this type of cell contains highly acidic materials that adversely affect protein and RNA 
extraction. Additional tissues were manually excised from each body part using scissors and 
tweezers. 
 
2.3. Molecular cloning of the AsTrx1 gene 
 
   Four degenerate primers from the conserved regions of known Trx family genes were 
designed: Trx-f, 5’-AAY GTN GGN TGY ATH CCN AA-3’; and Trx-r, 5’-TGN ACN CKR 
TRN CCC CAR TT-3’. Phage DNA amplified from the blood cell cDNA library from A. 
sydneiensis samea [16] was used as the PCR template. PCR was performed as follows: 100 
ng DNA, Trx-f and Trx-r primers (200 pmol each), deoxynucleotide triphosphate (dNTP, 2 
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nmol each), 1 × reaction buffer, and 2.5 U Taq DNA polymerase (TaKaRa, Inc.) in a final 
reaction volume of 50 µL. After denaturation at 94°C for 2 min, 30 cycles of PCR were 
performed (94°C for 30 s, 50°C for 30 s, and 72°C for 30 s), followed by a final extension at 
72°C for 5 min. After cloning the DNA fragment into a plasmid vector, the PCR product was 
sequenced by the dideoxy termination method using an ALFexpress DNA sequencer and 
Thermo Sequenase kit (GE Healthcare). Rapid amplification of cDNA ends (RACE) was 
performed using the following primers: TrxR2-3RACE-1, 5’-GAA GAA TCT ATT TCA AAA 
TG-3’ for the 3’-end; and TrxR2-5RACE-1, 5’-TTG AAC TGC AGT TGA TAA TG-3’ for the 
5’ end of the target DNA sequence using the same phage library DNA as the template. PCR 
fragments were then used for DNA sequencing. The combined full-length cDNA sequence of 
AsTrx1 was submitted to DDBJ/EMBL/Genbank (accession number AB911105). Predicted 
amino acid sequences were compared with known Trx family proteins by the neighbor-joining 
method using the ClustalW software.  
 
2.4. Preparation of recombinant proteins 
 
   Recombinant wild-type (WT) and mutant Vanabin2 proteins were prepared in accordance 
with procedures published previously [7,17]. Preparation of the AsTrx1 protein was 
essentially identical to the published procedures. In some experiments, recombinant proteins 
were used as fusion proteins, which were fused to Escherichia coli maltose-binding protein 
(MBP). 
   The cDNA region corresponding to the AsTrx1 full-length coding region was amplified by 
PCR using a specific primer set with artificial restriction sites, as follows: AsTrx1-F-EcoRI, 
5’-GAA TTC ATG CCT TTG ATT TTA A-3’; and AsTrx1-R-SalI, 5’-GTC GAC TTA CTT 
GTG GGT-3’. Amplified fragments were then digested with EcoRI and SalI, and ligated into 
the corresponding site of the pMAL-c2X expression vector (New England BioLabs Inc.). This 
vector contains a lac promoter and a coding region for MBP, to which the AsTrx1 coding 
region was ligated to produce a fusion protein. The plasmid was introduced into E. coli BL21 
cells. An overnight culture of non-induced E. coli cells bearing the expressed plasmid was 
diluted 1:10 in Luria broth (LB) medium containing 50 µg/mL ampicillin. Isopropyl 
β-D-1-thiogalactopyranoside (IPTG, 1 mM) was added to the medium, and cells were then 
cultured at 37°C for 7 h. The fusion protein was purified by amylose resin column 
chromatography according to the manufacturer’s protocol (New England BioLabs). The 
junction between MBP and AsTrx1 was cut using Factor Xa (1/200 wt/wt) at 4°C for 7 days. 
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After dialysis against 50 mM Tris-HCl, pH7.4, AsTrx1 was purified by DEAE-Sephacel anion 
exchange column chromatography (GE Healthcare) and high-performance liquid 
chromatography (HPLC) using a 5C18-AR300 widepore column (Nakalai Tesque, Inc.). The 
resulting recombinant protein had four additional amino acids (I-S-E-F), which were derived 
from the junction region at the N-terminus. Protein concentration was measured using the 
protein assay CBB reagent (Nakalai) with bovine serum albumin (BSA, Pierce Inc.) as a 
standard. 
   Cysteine residues at positions 33 and 36 in the putative redox active site were subjected to 
in vitro mutagenesis. A set of mutagenesis primers (5’-TTT GCA GAC TGG AGT GGA CCG 
AGC AAA GTT ATT-3’ and 5’-AAT AAC TTT GCT CGG TCC ACT CCA GTC TGC 
AAA-3’) were designed to mutate the two cysteines into serines. Each reaction mixture 
contained plasmid DNA (WT AsTrx1 in pMAL-c2X, 10 ng), 12.5 pmol each primer, and 
1 × KAPA HiFi Reaction Mix (KAPA Biosystems) in a total volume of 50 μL. After 
denaturation at 95°C for 2 min, 16 cycles PCR were performed (20 s at 98°C, 30 s at 57°C, 
and 6 min at 72°C). The restriction enzyme DpnI (20 U) was added to the reaction, and the 
mixture was incubated at 37°C for 60 min. An aliquot (5 μL) was used to transform 
competent E. coli DH5α cells. Following selection on LB plates with ampicillin, nucleotide 
sequences were determined using an ABI 3130 automated DNA sequencer (Applied 
Biosystems Japan Ltd.) at the Natural Science Center for Basic Research and Development, 
Hiroshima University (N-BARD). A representative plasmid (clone #uk43) was introduced 
into E. coli BL21 cells for protein expression, as well as the WT. 
 
2.5. Mobility shift assay by SDS-PAGE 
 
   The mobility shift assay was performed as described previously by [12]. Briefly, each 
reaction contained 1.5 µM Vanabin2, 0–3.0 µM AsTrx1, 0.1 mM DTT, and 50 mM Tris-HCl, 
pH 7.4 in a final volume of 100 µL. Immediately after mixing each reaction, 20-µL aliquots 
were mixed with loading dye lacking a reducing agent (62.5 mM Tris–HCl, 2.3% SDS, 10% 
glycerol, and 0.05% bromophenol blue), and resolved by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), followed by Coomassie Brilliant Blue 
(CBB) staining. 
 
2.6. Reductase assay using ESR spectrometry 
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   Reaction mixtures for the reductase assays were as follows: 1.25 µM Vanabin2, 0–2.5 µM 
AsTrx1, 0.1 mM DTT, 8.3 mM V(V), 3.3 mM EDTA, and 50 mM Tris-HCl, pH 7.4. The 
concentrations of V(V) and ethylenediaminetetraacetic acid (EDTA) were proportionally 
reduced where indicated. The final reaction volume was 120 µL. Vanabin2 and AsTrx1 were 
not added to negative controls, as described in the Figure legends. After incubation at 20°C 
for 2 h, 50-µL aliquots were removed from each reaction, placed in a quartz tube (5 × 100 mm, 
ST-X-5, Agri Co.), and frozen immediately in liquid nitrogen. ESR signals were recorded 
using the ELEXSYS-II E500 CW-ESR (Bruker BioSpin) with the ER 4112V temperature 
control system at the N-BARD. Samples were inserted into the quartz dewar, which was held 
in a steam of temperature-controlled nitrogen gas. ESR measurements were read at 79 K with 
a frequency of 9.4 GHz and a modulation (100 kHz) of 1 mT. ESR intensities were calculated 
by integrating the peak at 3/2⊥ peak in each ESR spectrum. Vanadyl sulfate (0–50 µM) mixed 
with 50 mM EDTA was used as the standard solution to calibrate the concentration of V(IV) 
products after enzymatic reactions. 
 
2.7. Reductase assay using ion-exchange chromatography 
 
   Reaction mixtures were the same as those described in Section 2.6 in a final volume of 
120 µL except for protein concentrations. 
   After incubation at 20°C for 2 h, 20 µL aliquots were removed from each reaction and 
injected into an ion exchange column (SI-50G, Shodex Inc.), equilibrated with 12 mM sodium 
hydrogen carbonate, 4 mM sodium carbonate, and 20 mM EDTA at a flow rate of 0.7 mL/min. 
Vanadium ions were detected by ultraviolet (UV) absorption at 282 nm and recorded by a 
D-7500 integrator (Hitachi). Under these conditions, V(IV) eluted 30 s after injection, while 
V(V) eluted 1 min following injection. The amount of reduced V(IV) was calculated as the 
relative area ratio calculated from each peak profile. 
 
2.8. Semi-quantitative RT-PCR 
 
   Total RNA extraction from ascidian tissues was performed as described previously [5]. 
Reverse transcription was performed using ReverTra Ace reverse transcriptase (TOYOBO) 
and the dT15 primer. PCR primers for each gene were as follows: AsTrx1, 5’-TTG CAG ACT 
GGT GTG GAC-3’ and 5’-CCA CGT TGC ATA TAC AAA TGT-3’;  VanabinP, 5’-GAA TTC 
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CGA AAG AAA AAG AAG-3’ and 5’-CTC GAG TCA ACC TTC AAA CAA-3’; β-actin, 
5’-GAC CTA TGC TGC TCT TGA-3’ and 5’-CAG GAT GGA TCC TCC AAT-3’; and EF-1α, 
5’-TTT GCG CCA ACC AGT CTT AC-3’ and 5’-AGC TCC TGA AAC TTG CAA GC-3’. 
Each PCR mixture contained reverse-transcribed DNA from 2 ng of total RNA, forward and 
reverse primers (10 pmol each), dNTPs (2 nmol each), 1 × PCR buffer, and 0.5 U HybriPol 
DNA Polymerase (Bioline, Inc) in a total reaction volume of 10 μL. After incubation at 94°C 
for 2 min, 27 cycles of PCR were performed (30 s at 94°C, 30 s at 50°C, and 30 s at 72°C). 
Amplified fragments were examined by 1.8% agarose gel electrophoresis and ethidium 
bromide staining. Relative band strength was calculated by densitometry using a FAS III gel 
documentation system (TOYOBO) and the ImageJ 1.46r software (http://imagej.nih.gov/ij/). 
Under these conditions, amplification of each gene was significant and did not reach 
saturation, as judged from the densitometric data by varying cycle number from 23 to 30. 
 
3. Results 
 
3.1. Cloning of the AsTrx1 gene 
 
   cDNA fragments related to a Trx gene from the A. sydneiensis samea blood cell cDNA 
library were initially amplified by PCR using a pair of degenerate primers corresponding to 
conserved amino acid sequences of known Trx1 family proteins. We then performed 5’- and 
3’-RACE to obtain the full-length cDNA sequence from the same cDNA library. The 
full-length cDNA sequence contained a single, long open reading frame (ORF) 324 
nucleotides in length, including the stop codon, which encoded a protein 107 amino acids in 
length. The amino acid sequence deduced from the cDNA clone showed striking similarities 
to Trx1 proteins from various organisms (Fig. 1). The predicted amino acid sequence 
contained a putative redox active motif (C-G-P-C), which is commonly found in all Trx1 
proteins. Therefore, we concluded that the cDNA clone corresponded to a Trx1 homolog in A. 
sydneiensis samea, which we refer to as AsTrx1.  
 
3.2. Mobility shift assay 
 
   Vanabin2 changes its conformation in the presence of reducing agents, and these changes 
can be detected as a shift in mobility on SDS-PAGE gels [12]. Here, we examined the 
structural changes of Vanabin2 upon addition of the reduced form of AsTrx using gel 
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electrophoresis. In the present study, 0.1 mM DTT was used as the reducing agent since we 
have been unable to clone TR, and our previous study revealed that Vanabin2 mobility did not 
change in the presence of 0.1 mM DTT [12]. 
   Using an E. coli expression system, we prepared recombinant Vanabin2 and AsTrx1 
proteins (Fig. 2A). Recombinant Vanabin2, containing nine fully oxidized disulfide bonds, 
was observed by SDS-PAGE at a position corresponding to 14 kDa [12]. In the presence of 
0.1 mM DTT, Vanabin2 migrated to a position corresponding to a much larger size in 
response to increasing concentrations of AsTrx1 (Fig. 2B). The apparent size of Vanabin2 
peaked in the presence of AsTrx1 (1:1 ratio), but the apparent size did not achieve that of the 
fully reduced form (20 kDa) [12], suggesting that the disulfide bonds of Vanabin2 were 
partially reduced to facilitate cleavage in the presence of a low concentration of DTT and a 
stoichiometric ratio of 1:1 with AsTrx1. 
 
3.3 Coupled assays for V(V)-reductase activity in Vanabin2–AsTrx1 cascade 
 
   TrxR is necessary to examine V(V)-reduction by the cascade described in Scheme 2, but 
we have been unsuccessful cloning TrxR from A. sydneiensis samea. Therefore, we utilized 
DTT as the initial reducing agent. As described in the previous section, the disulfide bonds of 
Vanabin2 were not cleaved by 0.1 mM DTT, but were partially reduced to cleave in the 
presence of 0.1 mM DTT and at a 1:1 stoichiometric ratio with AsTrx1. Thus, in the presence 
of DTT and AsTrx1, the redox cascade in Scheme 3 was examined. To measure the rate of 
V(V) reduction, V(IV) was directly measured by ESR and ion-exchange chromatography. 
   Results are summarized in Figure 3. Briefly, when 0.1 mM DTT was added to V(V) 
without AsTrx1 and Vanabin2, no reduction occurred. In the presence of either AsTrx1 or 
Vanabin2, a low level of V(V)-reduction was observed. When both AsTrx1 and Vanabin2 
were mixed in the presence of 0.1 mM DTT, AsTrx1-dependent reduction of V(V) was 
observed. 
   The reduction of V(V) by Vanabin2 was catalyzed by SH/SS exchange between Vanabin2 
and V(V) [17]. Here, we determined that the cascade including AsTrx1 is also dependent on 
cysteine residues in Vanabin2. As shown in Figure 4, the V2mSS1-9 mutant lacking all nine 
cysteine pairs did not catalyze the reduction of V(V). Thus, the last step of the Trx cascade 
(Schemes 2 and 3) is similar to that in the GSH cascade (Scheme 1). 
   The C-X-X-C motif, which is commonly found in Trxs, has been revealed to be the redox 
active site that reduces disulfide bonds by a ping-pong mechanism [18]. In AsTrx1, the 
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C-G-P-C sequence from positions 33 to 36 corresponds to this motif (Fig. 1). To assess the 
contribution of this motif to the reduction of Vanabin2, the possible redox active cysteines 
were deleted from AsTrx1 by substitution to serines. This C33SC36S mutant contributed 
approximately half of the V(V)-reduction by Vanabin2 when the initial concentration of V(V) 
was 8.3 mM (Fig. 5A).  
   Kinetic analysis was performed by varying the V(V) concentration from 0.25 to 8.3 mM 
(Fig. 5B and C). Vapp and Kapp values for Vanabin2-catalyzed V(V) reduction in this system 
were 0.066 mol-V(IV)/min/mol-Vanabin2 and 0.19 mM, respectively. As compared to the 
observed Vapp and Kapp values in the GSH system (1.15 mol-NADPH/min/mol-Vanabin2 and 
0.51 mM, respectively) [12], Vapp was ~20-fold lower than that of the GSH system, but the 
Kapp was 2.7-fold lower than that of the GSH system. These results suggest that the Trx 
system may act in blood cells, but prevails only at low V(V) concentrations. 
 
3.4 Coupled assays for V(V)-reductase activity in Vanabin2–human Trx1 cascade 
 
   In order to assess whether the redox coupling reaction is specific to ascidian thioredoxin 
or not, we performed an coupled assay using human Trx1 (HsTrx1). The purity of 
commercially obtained HsTrx1 was examined by SDS-PAGE (Fig. 6A), and the protein was 
used without any further purification. As a result, HsTrx1-dependent reduction of V(V) was 
observed (Fig. 6B). The final product V(IV) was about 50% more than that using AsTrx1 as a 
component. This result suggests that the reductase-coupling function of thioredoxin is 
conserved between ascidians and humans. 
 
3.5 Tissue localization of AsTrx1 
 
   To examine the tissue localization of AsTrx1, we performed semi-quantitative RT-PCR 
analysis. Two housekeeping genes, β-actin and elongation factor-1α (EF-1α), were tested to 
determine whether they could be used as controls. The results revealed that expression of 
these housekeeping genes was lower in blood cells than in the other three tissues examined 
(Fig. 6). Since the expression profiles were similar, these genes were used as controls. 
   AsTrx1 expression was similar to that of the housekeeping genes in blood cells, but was 
undetected in the brachial sac, and very low in the intestine and muscle. When expression of 
AsTrx1 was normalized to that of β-actin, the expression level in blood cells was 20- or 
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10-fold higher than in the brachial sac and muscle, respectively. When normalized to EF-1α, 
its expression in blood cells was 30- or 15-fold higher than that in the brachial sac and muscle, 
respectively. Thus, the expression of AsTrx1 in blood cells is relatively high. 
 
4. Discussion 
 
   This study is the first to report the reduction of vanadium in the Trx cascade. In this study, 
we first isolated a homolog of Trx from blood cells of the vanadium-rich ascidian A. 
sydneiensis samea. The cDNA clone, AsTrx1, encoded a protein 107 amino acids in length, 
which is closely related to Trx1 in animals (Fig. 1). Generally, most animals possess two Trxs 
and several Trx-related proteins [19,20]. Trx1 is expressed in the cytoplasm, while Trx2 is 
expressed in mitochondria [21,22]. Thus far, we have been unable to isolate Trx2 from this 
species of ascidian, although we attempted to obtain it using PCR with several pairs of 
degenerate primers. This problem could be due to increased sequence diversity in Trx2 
compared with Trx1, and is an important limitation in our trials. 
   Both Trx1 and Trx2 have been identified in genome and EST analyses on another ascidian, 
Ciona intestinalis, and are registered in public databases under the GenBank accession 
numbers AK112286 and AK114174.1, respectively. A previous report indicated that Trx1 is 
expressed in C. intestinalis blood cells, and its expression is constant during development [23]. 
In our previous microarray study, we determined that the expression of Trx1 and Trx2 was not 
significantly affected by treatment with excess vanadium [24]. To our knowledge, detailed 
studies on Trx in C. intestinalis have yet to be published. 
   This study is also the first to report metal reduction by the Trx cascade in eukaryotes. 
Reduction of metal ions by the Trx system has been reported for U(VI) and Cr(VI) in bacteria. 
In the mre operon of the Desulfovibrio desulfuricans bacterium, a novel oxidoreductase MreG 
was demonstrated to reduce U(VI) and Cr(VI) in the presence of Trx, TrxR and NADPH [25]. 
It is proposed that MreG functions to protect cells against oxidation by metal ions. A similar 
reduction cascade was reported for As(V), although it is not a metal. A family of ArsC 
reductase proteins, including a typical protein from the E. coli plasmid R773 ArsC, can reduce 
As(V) to As(III) using Grx and GSH as reductants [26]. Another family represented by the 
Staphylococcus aureus plasmid, pI258 ArsC, also uses Trx as a reductant [27]. Similar 
reduction cascades could exist in other eukaryotes. Since vanabins are only found in 
vanadium-rich ascidians, another type of reductase could participate in such cascades. 
   In this study, it was revealed that reduction of V(V) was observed when human Trx1 was 
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added as a component (Fig. 6B). This must not occur in nature, but the fact suggests the 
highly conserved structure and function of AsTrx and human Trx1. Structural modeling 
indicated that their structures were predicted to be highly conserved (RMSD = 0.088) (Fig. 8). 
This high level of structural homology could explain the combination of Vanabin2 from the 
ascidian and human Trx1 works in vitro. 
   In our previous work [12], we hypothesized that Vanabin2 is reduced by GSH (Scheme 1). 
In this study, we hypothesized that Vanabin2 is reduced by Trx (Scheme 2). It was proved that 
the cascade including AsTrx1 is also dependent on cysteine residues in Vanabin2 (Fig.4). Thus, 
the last step of the Trx cascade is similar to that in the GSH cascade. When the possible redox 
active cysteines were deleted from AsTrx1, the reductase activity fell down to about half (Fig. 
5A), suggesting the possibility of participation of other cysteines in AsTrx. In both cascades, 
the reducing potential is provided by NADPH, which is produced in the pentose phosphate 
pathway that is exclusively localized in vanadocytes [16,28,29]. Thus, these two cascades 
could exist and function together in the cytoplasm of vanadocytes. Potential differences 
between these two cascades may be: (1) the availability of GSH and Trx, and (2) kinetic 
parameters. 
   Cysteines with low pKa values are ionized and can be highly reactive in buffers at 
physiological pH [30,31]. As summarized in the review by Cheng et al., pKa values for Cys32 
in E. coli Trx range from 6.3 to 10.0, while that of Cys35 is less well-defined, somewhere 
between 7.0 and 14.0 [30]. The pKa value for the thiol in GSH is 8.7. Judging from these pKa 
values, it is difficult to conclude which cascade is prevailing in the cytoplasm of vanadocytes. 
The most probable hypothesis is that these two cascades coexist and work together, but the 
relative contribution depends on other factors, such as redox state, concentrations of GSH and 
Trx, and the concentration of V(V) in the cytoplasm. 
   A link between Trx and GSH systems has been reported in yeast and bacteria [32]. Yeast 
lacking the glutathione reductase gene (GLR1) requires either one of the two Trx genes for 
growth under aerobic conditions [33]. Moreover, loss of both Trx genes results in elevated 
levels of GSSG, indicating a link between the Trx and GSH systems [33]. In E. coli, both the 
Trx and glutaredoxin systems contribute to reduction of disulfide bonds in alkaline 
phosphatase, and these systems can partially replace each other in vivo [34]. Thus, at least in 
these microorganisms, Trx and GSH systems have overlapping functions and can compensate 
for each other. The contribution of Trx and GSH on V(V)-reductase function of vanabins in 
ascidian blood cells should be examined in vivo using gene-knockout experiments. 
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Figure and Scheme legends 
 
 
Scheme 1. Redox cascade including glutathione (GSH). 
 
 
Scheme 2. Possible redox cascade including thioredoxin (Trx). 
 
 
Scheme 3. Experimental cascade used to examine the cascade in Scheme 2. Reduced DTT 
supplies the reduction potential in this cascade. 
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Fig. 1. Amino acid sequences of Trxs from Ascidia sydneiensis samea and closely related 
Trxs from several representative animals. Asy, AsTrx1 from Ascidia sydneiensis samea (this 
study); Cin, Ciona intestinalis Trx1 (KEGG ID: 100183957); Hsa, Homo sapiens Trx1 
(7295); Mmu, Mus musculus Trx1 (22166); Dre, Danio rerio Trx1 (zebrafish) (336637); Spu, 
Strongylocentrotus purpuratus Trx1 (purple sea urchin) (752709). Numbers indicate amino 
acid positions in Asy. Identical or conserved residues are indicated in red (6/6), green (5/6) 
and blue (4/6). The redox active site (C-G-P-C) is boxed. 
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Fig. 2. AsTrx1 and Vanabin2: protein expression, purification and mobility shift assay. (A) 
AsTrx1 and Vanabin2 were purified using amylose resin as a fusion protein (open arrowheads, 
lane F), and further purified by anion-exchange column chromatography after digestion with 
Factor Xa (solid arrowheads, lane X). (B) Mobility shift assay on Vanabin2 by the addition of 
increasing amounts of AsTrx1. M, 14-kDa marker protein. 0–3.0 µM AsTrx1 was added to a 
constant amount of Vanabin2 (1.5 µM) in the presence of 0.1 mM DTT. Note that the mobility 
of Vanabin2 shifted from 14 kDa (apparent size) to a larger size, depending on the 
concentration of AsTrx1. 
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Fig. 3. Reduction of V(V) by Vanabin2 in the presence of AsTrx1 and DTT. Results from a 
representative experiment. Common reaction components included 0.1 mM DTT, 8.3 mM 
V(V), 3.3 mM EDTA, and 50 mM Tris-HCl, pH 7.4. Vanabin2 and AsTrx1 were not added to 
negative controls. Incubation temperature and time were 20°C and 2 h, respectively. Plus 
symbols indicate the addition of 1.25 µM Vanabin2 or AsTrx1, and increasing concentrations 
of AsTrx1 were added as indicated. The vertical axis indicates relative differential ESR peak 
height. 
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Fig. 4. Reduction of V(V) by a combination of wild-type (WT) or mutant Vanabin2 with WT 
AsTrx1. Common reaction components included 2.5 µM WT AsTrx1, 0.1 mM DTT, 8.3 mM 
V(V), 3.3 mM EDTA, and 50 mM Tris-HCl, pH 7.4 in a final volume of 120 µL. WT 
Vanabin2-MBP or a mutant Vanabin2-MBP lacking all 18 cysteine residues (m1-9) were 
added at a concentration of 1.25 µM, as indicated. Incubation temperature and time were 
20°C and 2 h, respectively. The vertical axis indicates relative area ratio for V(IV) calculated 
from each peak profile by ion-exchange chromatography. Results are presented as the means 
± standard deviation (S.D.), n = 4. 
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Fig. 5. Reduction of V(V) by a combination of WT Vanabin2 and WT or C33SC36S mutant 
AsTrx1. Common reaction components included 0.1 mM DTT and 50 mM Tris-HCl, pH 7.4. 
Incubation temperature and time were 20°C and 2 h, respectively in a final reaction volume of 
120 µL. (A) Comparison of the reduction by WT Vanabin2 combined with WT or mutant 
AsTrx1. Vanabin2 was added at a concentration of 1.25 µM, as indicated by a plus sign. WT 
or mutant AsTrx1 was added at a concentration of 2.5 µM, as indicated by a plus sign. V(V) 
(8.3 mM) and EDTA (3.3 mM) were also added. The vertical axis indicates ESR intensity, and 
results are presented as the means ± S.D., n = 3. (B) Kinetic analysis of V(V)-reduction by 
Vanabin2 (1.25 µM) in the presence of WT or mutant AsTrx1 (2.5 µM). The horizontal axis 
indicates the initial concentration of V(V). The vertical axis indicates ESR intensity, and 
results are presented as the means ± S.D., n = 2-4. (C) Lineweaver–Burk plots calculated from 
(B). In these experiments, ESR intensity was calculated as an integrated value for 3/2⊥ peak, 
and the actual V(IV) concentration was determined using the equation [V(IV)] (µM) = 
0.44 × ESR intensity - 0.31. 
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Fig. 6. Reduction of V(V) by a combination of wild-type Vanabin2 with AsTrx1 or human 
Trx1 (HsTrx1). (A) Synthesized or commercially obtained proteins. lane M, molecular weight 
marker. lane1, Vanabin2. lane2, HsTrx1. lane 3, AsTrx1. Note that AsTrx was finally purified 
by HPLC. A small amount of carrier MBP remains (~45 kDa) but it was neglected in this 
assay. (B) Results of V(V)-reduction assays. Common reaction components included 0.4µM 
Vanabin2, 0.1 mM DTT, 8.3 mM V(V), 3.3 mM EDTA, and 50 mM Tris-HCl, pH 7.4 in a 
final volume of 120 µL. AsTrx1 or HsTrx1 was added at a concentration of 0.8 µM, as 
indicated. Incubation temperature and time were 20°C and 2 h, respectively. The vertical axis 
indicates relative area ratio for V(IV) calculated from each peak profile by ion-exchange 
chromatography. Results are presented as the means ± standard deviation (S.D.), n = 3 - 4. 
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Fig. 7. Expression of AsTrx1 in tissues/organs of Ascidia sydneiensis samea examined by 
conventional semi-quantitative RT-PCR. Results from a representative experiment. PCR 
products amplified from the same amount of cDNA under the same cycle conditions were 
loaded. VanabinP, β-actin and EF-1α were used as controls. Under these conditions, the band 
strength was not saturated and was comparable among genes and tissues. BC, blood cells; BR, 
branchial sac; IN, intestine; MU, muscle. 
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Fig. 8. Homology modeling of AsTrx1. (A) Superimposed structures of AsTrx1 (magenta) and 
HsTrx1 (cyan). (B) Close-up image of the redox-active cysteine motifs (C33 and C36 in 
AsTrx1, and C31 and C34 in HsTrx1). Structures were calculated by SwissModel workspace 
(http://swissmodel.expasy.org/workspace/) based on the structure of HsTrx1 (PDB ID: 1ertA), 
and aligned and pixilated by MacPyMol software. RMSD was 0.088 (571 to 571 atoms).  
 
 
 
 
 
 
 
